Urolithin A vs CoQ10: How They Compare

Urolithin A and CoQ10 are both talked about as "mitochondrial" supplements, but they work on completely different parts of the same machinery. One helps your cells clear out and renew worn mitochondria; the other is a molecule those mitochondria use to make energy. Understanding that distinction is the fastest way to decide which one fits your goal, or whether they belong together.

The one-sentence difference

Coenzyme Q10 (CoQ10, also sold as ubiquinone or the reduced form ubiquinol) is a fat-soluble molecule your body makes and stores inside the mitochondrial membrane, where it shuttles electrons through the electron transport chain during ATP production and also acts as an antioxidant. Urolithin A works one level up: it is a gut postbiotic that supports mitophagy, the housekeeping process by which cells identify aging or damaged mitochondria and recycle them so healthier ones can take their place. Put simply, CoQ10 is a part that keeps the existing engine running, while urolithin A supports the maintenance crew that renews the engines themselves.

How CoQ10 works

CoQ10 sits inside complexes I, II and III of the electron transport chain. As your cells burn nutrients for energy, electrons are passed down this chain and CoQ10 carries them between steps, a role that is directly tied to producing adenosine triphosphate (ATP), the cell's energy currency. It also functions as a lipid-soluble antioxidant, helping protect membranes from oxidative wear.

Your body synthesizes CoQ10 on its own, and tissue levels tend to decline gradually with age. Certain medications, most notably statins, can lower circulating CoQ10 because they share part of the same biochemical pathway. That is why CoQ10 is one of the more commonly discussed supplements for people on those medications and for general cardiovascular and energy support. Because it is fat-soluble, absorption is modest and is improved by taking it with a meal containing fat; ubiquinol is often marketed as a more bioavailable form. CoQ10 is condition-adjacent for heart and metabolic topics, so treat it as general support and talk to your doctor before using it to address any medical concern or alongside prescription medication.

How urolithin A works

Urolithin A is not something you eat directly. Your gut microbiome makes it from ellagitannins, compounds found in pomegranates, walnuts, raspberries and other berries. The catch is that only some people carry the microbial species needed to convert those precursors efficiently, which is why two people eating the same pomegranate can end up with very different urolithin A levels. Supplementing the finished molecule bypasses that lottery.

Once present, urolithin A supports mitophagy. Instead of feeding the energy-production step the way CoQ10 does, it supports the quality-control step, encouraging cells to clear worn mitochondria so the overall pool stays healthier. For a deeper walkthrough of that biology, see our guide to mitophagy and the broader mitochondrial health overview.

The evidence, side by side

Urolithin A: human trials first

The urolithin A human record is young but real, and we label it honestly. The first-in-human study, Andreux and colleagues in Nature Metabolism (2019), found the molecule was safe and well tolerated at doses up to 1,000 mg per day and produced a mitochondrial gene-expression signature in older adults. In a 2022 JAMA Network Open randomized trial (Liu, D'Amico et al.), older adults taking urolithin A for roughly four months showed improved muscle endurance, measured as the number of muscle contractions before fatigue. Singh and colleagues (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg arms in middle-aged adults over four months and reported benefits to muscle strength and aspects of exercise performance. A 2025 Nature Aging randomized trial (roughly 28 days) reported support for immune-cell mitochondrial health in midlife adults, and a 2024 trial in the Journal of the International Society of Sports Nutrition looked at endurance and recovery markers in resistance-trained men over eight weeks. A 2024 systematic review in Ageing Research Reviews is the fair summary: the human evidence is genuinely promising but still emerging, built on relatively short trials with modest participant numbers.

Urolithin A: preclinical foundation

The mechanism traces back to Ryu and colleagues (2016, Nature Medicine), foundational animal and cell work showing urolithin A triggered mitophagy, extended lifespan in C. elegans, and improved muscle function in rodents. Separate preclinical work (D'Amico et al., 2022, Aging Cell) explored joint and cartilage mitochondrial health in osteoarthritis models. These are animal and cell studies, not human proof, and we flag them as such.

CoQ10: a longer but mixed record

CoQ10 has been studied for decades across energy, cardiovascular and healthy-aging contexts, and its role in the electron transport chain is textbook biochemistry. That said, human supplement trials have produced mixed results depending on the population and outcome measured, and much of the strongest interest centers on people with low baseline levels or those on statins. Its evidence base is older and broader than urolithin A's, but "more years of study" does not automatically mean "stronger effect" for a given goal. Neither compound is a treatment for any disease.

Are they complementary?

Because they act on different stages of the same system, urolithin A and CoQ10 are not direct substitutes and can be viewed as complementary rather than competing. CoQ10 supports the moment-to-moment work of energy production inside existing mitochondria; urolithin A supports the renewal of the mitochondrial pool over time. Some people who care broadly about mitochondrial health use both. There is no head-to-head human trial comparing the two, so anyone stacking them is reasoning from mechanism, not from a study that pitted one against the other. If you take medication or manage a health condition, run any combination past your doctor first, since CoQ10 in particular can interact with certain drugs.

How to choose by goal

Choose urolithin A if...

Your priority is muscle strength, muscle endurance, exercise performance or general cellular renewal as you age, and you want the option with recent, targeted human randomized trials behind those specific outcomes. It is also the more logical pick if you eat few pomegranates, walnuts or berries, or suspect you are a poor natural converter. See urolithin A for muscle and urolithin A for energy for goal-specific detail.

Choose CoQ10 if...

You are specifically interested in supporting energy production within existing mitochondria or general cardiovascular wellness, or you take a statin and want to discuss replenishing CoQ10 with your clinician. Because these are heart- and metabolism-adjacent topics, this is a doctor conversation, not a self-diagnosis. CoQ10 is not a treatment and does not address the mitophagy pathway urolithin A targets. If your handle exists for it, our what is CoQ10 primer covers the basics.

A practical starting point

For urolithin A, the clinically studied range is 500 to 1,000 mg per day, with 1,000 mg at the top of that range and the dose used in several of the strength and endurance trials. For more on getting started, see our how to take urolithin A and dosage guides, or the full urolithin A guide. When comparing finished products, our roundup of the best urolithin A gummies explains what to look for on a label.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.